Busy provider looking for healthcare news? Check out The Rundown. FDA Await DEA Decision on Marijuana Pharmaceutical The US Food and Drug Administration (FDA) approved the first cannabidiol (CBD) for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of epilepsy. Approval of the marijuana-derived drug, Epidiolex, followed three randomized, placebo-controlled studies on …